MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Data Science_Biosimulation
Certara, Inc. (NASDAQ:CERT)
Organization & Developments: Certara
Parents
Certara, Inc. (NASDAQ:CERT)
Children
*Biosimulation helps reduce costs and duration of drug discovery, preclinical and clinical research, regulatory submissions and market access.
*Biosimulation software can replace in vivo (human) clinical trials - in certain cases - with in silico trials.
*Certara (CERT) provides a suite of biosimulation software to pharma companies.
*The company is using biosimulation software to help streamline the drug discovery process by enabling virtual trials to predict how drugs might behave in patients.
*Their software includes biosimulation, regulatory submissions and value communication, and respectively, these provide services for drug discovery & development with biosimulation, regulatory science, and market access.
2021: Certara: Using Computer Modelling To Aid Biopharma R&D
2022: Certara: A Story To Watch_ seekingalpha.com
2023: Circling Back On Certara (NASDAQ:CERT)
2024: Certara: Still Awaiting Consistent Growth
Jumps
Finance & Acquisitions: Certara
Key People: Certara